GB0711957D0 - Formulations - Google Patents
FormulationsInfo
- Publication number
- GB0711957D0 GB0711957D0 GBGB0711957.1A GB0711957A GB0711957D0 GB 0711957 D0 GB0711957 D0 GB 0711957D0 GB 0711957 A GB0711957 A GB 0711957A GB 0711957 D0 GB0711957 D0 GB 0711957D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
- A01N37/38—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system
- A01N37/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system having at least one carboxylic group or a thio analogue, or a derivative thereof, and one oxygen or sulfur atom attached to the same aromatic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/609—Amides, e.g. salicylamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Agronomy & Crop Science (AREA)
- Pain & Pain Management (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0711957.1A GB0711957D0 (en) | 2007-06-21 | 2007-06-21 | Formulations |
GB0811139A GB2450608B (en) | 2007-06-21 | 2008-06-18 | New use |
PCT/GB2008/002069 WO2008155535A1 (en) | 2007-06-21 | 2008-06-18 | Use of halogenated salicylanilides for the treatment of acne |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0711957.1A GB0711957D0 (en) | 2007-06-21 | 2007-06-21 | Formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0711957D0 true GB0711957D0 (en) | 2007-08-01 |
Family
ID=38352598
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0711957.1A Ceased GB0711957D0 (en) | 2007-06-21 | 2007-06-21 | Formulations |
GB0811139A Expired - Fee Related GB2450608B (en) | 2007-06-21 | 2008-06-18 | New use |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0811139A Expired - Fee Related GB2450608B (en) | 2007-06-21 | 2008-06-18 | New use |
Country Status (2)
Country | Link |
---|---|
GB (2) | GB0711957D0 (en) |
WO (1) | WO2008155535A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2456376A (en) * | 2008-12-22 | 2009-07-15 | Syntopix Ltd | Antibacterial/anti-acne formulations comprising a halogenated salicylanilide in combination with one or more anti-acne agents |
US20170258816A1 (en) | 2014-09-12 | 2017-09-14 | Antibiotx Aps | Antibacterial Use of Halogenated Salicylanilides |
GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
CN105638690B (en) * | 2016-03-09 | 2017-10-24 | 安徽省农业科学院植物保护与农产品质量安全研究所 | A kind of composition pesticide containing emamectin benzoate and niclosamide ethanolamine salt |
GB201604484D0 (en) * | 2016-03-16 | 2016-04-27 | Antibiotx Aps And Københavns Uni University Of Copenhagen | Topical antibacterial compositions |
BR112019019519A2 (en) | 2017-03-21 | 2020-04-22 | Novalead Pharma Inc | therapeutic agent for the inhibition of phosphodiesterase and its related disorders |
GB201813876D0 (en) | 2018-08-24 | 2018-10-10 | Antibiotx As | Treatment |
CN113347977A (en) | 2018-11-02 | 2021-09-03 | 联合疗法公司 | Halogenated salicylanilides for the treatment of dermatitis symptoms |
WO2020089467A1 (en) | 2018-11-02 | 2020-05-07 | UNION therapeutics A/S | Dosage regimen |
WO2020176067A1 (en) | 2019-02-25 | 2020-09-03 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with h. pylori using a halogenated salicylanilide |
US11419834B2 (en) | 2019-02-25 | 2022-08-23 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55129256A (en) * | 1979-02-28 | 1980-10-06 | Isao Ozawa | Antifungal compound |
EP0487973B1 (en) * | 1990-11-26 | 1996-03-27 | Bayer Corporation | Topical lotion containing Niclosamide |
EP1129713A1 (en) * | 2000-02-29 | 2001-09-05 | New Pharma Research Sweden AB | Veterinary compositions for the treatment of parasitic diseases |
US7201914B2 (en) * | 2002-05-17 | 2007-04-10 | Xantech Pharmaceuticals, Inc. | Combination antiperspirant and antimicrobial composition |
AU2003249244A1 (en) * | 2002-07-15 | 2004-02-02 | Combinatorx, Incorporated | Methods for the treatment of neoplasms |
GB0316377D0 (en) * | 2003-07-12 | 2003-08-13 | Norbrook Lab Ltd | Parasiticidal composition |
-
2007
- 2007-06-21 GB GBGB0711957.1A patent/GB0711957D0/en not_active Ceased
-
2008
- 2008-06-18 WO PCT/GB2008/002069 patent/WO2008155535A1/en active Application Filing
- 2008-06-18 GB GB0811139A patent/GB2450608B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2008155535A1 (en) | 2008-12-24 |
GB0811139D0 (en) | 2008-07-23 |
GB2450608A (en) | 2008-12-31 |
GB2450608B (en) | 2009-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0711656D0 (en) | Formulations | |
GB2435419B (en) | Formulations | |
GB0716385D0 (en) | Formulations | |
EP2046930A4 (en) | Rhamnolipid-based formulations | |
ZA200908969B (en) | Formulations | |
GB0605780D0 (en) | Formulations | |
GB0815435D0 (en) | Formulations | |
GB2459691B (en) | Formulations | |
GB0823269D0 (en) | Formulations | |
GB0809979D0 (en) | Formulations | |
GB0718409D0 (en) | Formulations | |
GB0711957D0 (en) | Formulations | |
GB0821789D0 (en) | Formulations | |
GB0610336D0 (en) | Formulations | |
GB0707463D0 (en) | Formulation | |
EP2307021A4 (en) | Formulations | |
GB0810232D0 (en) | Formulations | |
GB0718404D0 (en) | Formulations | |
GB0705179D0 (en) | Formulations | |
GB0921378D0 (en) | Formulations | |
GB0916030D0 (en) | Formulations | |
GB0822171D0 (en) | Temisartan formulations | |
EP2142200A4 (en) | Homeopathy-based formulation | |
GB0713886D0 (en) | Formulations | |
GB0710900D0 (en) | Formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |